TAS-114, a Dual dUTPase/DPD Inhibitor, Improves Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy
The fluoropyrimidine 5-fluorouracil (5-FU) is an antimetabolite drug that is widely used for the treatment of cancer, particularly for colorectal cancer. Fluorouracil is part of a group of chemotherapy drugs known as anti-metabolites. Anti-metabolites are similar to normal body molecules but they have a slightly different structure. These differences...